You are here: Home » News » Infections » Malaria
Category: Malaria
Davis will oversee PATH’s annual budget of $305 million, a staff of nearly 1,200, and a portfolio of projects based in PATH offices in 22 countries. He succeeds Dr. Christopher J. Elias, who left PATH to become president of the Global Development Program at the Bill & Melinda Gates Foundation.
A malaria vaccine developed by the pharmaceutical company GSK and Seattle’s PATH has been shown to halve the risk of severe malaria in African children.
Despite the world economic crisis, funding for global health from both public and private donors continues to rise, albeit more slowly, according to a report by the Institute for Health Metrics and Evaluation at the University of Washington in Seattle.
But aid is not necessarily going where the need is greatest, the report finds.
Sandi Doughton reports about new developments in the Foundation’s initiative.
Two-hour forum on reforming U.S. global health practices was held in Seattle Thursday will be available online.
Seattle global health blogger Tom Paulson reports on PATH’s World Malaria Day conference.
Recent Comments